Seventh Sense Biosystems has obtained $1.9 million in a round of debt funding from five unnamed investors. Last summer, the Cambridge, Mass.-based startup also raised $10 million in a Series A round that it said would finance the development and commercialization of its Touch Activated Phlebotomy device, its first blood collection product.
Mass. blood collection device firm obtains $1.9M
SmartBrief Job Listings for Health Care
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|
|Director Account Management||
Samaritan Health Services
|Hospital Medical Device Sales||
Linda Hertz Group